Literature DB >> 19553336

Bluetongue virus targets conventional dendritic cells in skin lymph.

Behzad Hemati1, Vanessa Contreras, Céline Urien, Michel Bonneau, Haru-Hisa Takamatsu, Peter P C Mertens, Emmanuel Bréard, Corinne Sailleau, Stéphan Zientara, Isabelle Schwartz-Cornil.   

Abstract

Bluetongue virus (BTV) is the etiological agent of bluetongue, a hemorrhagic disease of ruminants (particularly sheep), which causes important economic losses around the world. BTV is transmitted primarily via the bites of infected midges, which inject the virus into the ruminant's skin during blood feeding. The virus initially replicates in the draining lymph node and then disseminates to secondary organs where it induces edema, hemorrhages, and necrosis. In this study, we show that ovine conventional dendritic cells (cDCs) are the primary targets of BTV that contribute to the primary dissemination of BTV from the skin to draining lymph nodes. Lymph cDCs support BTV RNA and protein synthesis, as well as the production of infectious virus belonging to several different BTV serotypes, regardless of their level of attenuation. Afferent lymph cell subsets, other than cDCs, showed only marginal levels of BTV protein expression. BTV infection provoked a massive recruitment of cDCs to the sheep skin and afferent lymph, providing cellular targets for infection. Although BTV productively infects cDCs, no negative impact on their physiology was detected. Indeed, BTV infection and protein expression in cDCs enhanced their survival rate. Several serotypes of BTV stimulated the surface expression of the CD80 and CD86 costimulatory molecules on cDCs as well as the mRNA synthesis of cytokines involved in inflammation and immunity, i.e., interleukin-12 (IL-12), IL-1beta, and IL-6. BTV-infected cDCs stimulated antigen-specific CD4 and CD8 proliferation as well as gamma interferon production. BTV initially targets cDCs while preserving their functional properties, reflecting the optimal adaptation of the virus to its host cells for its first spread.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553336      PMCID: PMC2738198          DOI: 10.1128/JVI.00626-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Enrichment for a CD26hi SIRP- subset in lymph dendritic cells from the upper aero-digestive tract.

Authors:  Mathieu Epardaud; Michel Bonneau; Fabrice Payot; Corinne Cordier; Jérôme Mégret; Chris Howard; Isabelle Schwartz-Cornil
Journal:  J Leukoc Biol       Date:  2004-06-14       Impact factor: 4.962

Review 2.  Pathogenesis of viral hemorrhagic fever.

Authors:  Mike Bray
Journal:  Curr Opin Immunol       Date:  2005-08       Impact factor: 7.486

3.  Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Authors:  Siddhartha Mahanty; Karen Hutchinson; Sudhanshu Agarwal; Michael McRae; Pierre E Rollin; Bali Pulendran
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  Infection kinetics, prostacyclin release and cytokine-mediated modulation of the mechanism of cell death during bluetongue virus infection of cultured ovine and bovine pulmonary artery and lung microvascular endothelial cells.

Authors:  Christopher D DeMaula; Mark A Jutila; Dennis W Wilson; N James MacLachlan
Journal:  J Gen Virol       Date:  2001-04       Impact factor: 3.891

5.  A possible overwintering mechanism for bluetongue virus in the absence of the insect vector.

Authors:  H Takamatsu; P S Mellor; P P C Mertens; P A Kirkham; J N Burroughs; R M E Parkhouse
Journal:  J Gen Virol       Date:  2003-01       Impact factor: 3.891

6.  Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells.

Authors:  Sylvain Baize; Jérôme Kaplon; Caroline Faure; Delphine Pannetier; Marie-Claude Georges-Courbot; Vincent Deubel
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

7.  Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.

Authors:  Catharine M Bosio; M Javad Aman; Case Grogan; Robert Hogan; Gordon Ruthel; Diane Negley; Mansour Mohamadzadeh; Sina Bavari; Alan Schmaljohn
Journal:  J Infect Dis       Date:  2003-11-14       Impact factor: 5.226

8.  Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.

Authors:  Thomas W Geisbert; Howard A Young; Peter B Jahrling; Kelly J Davis; Elliott Kagan; Lisa E Hensley
Journal:  J Infect Dis       Date:  2003-11-14       Impact factor: 5.226

9.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

Authors:  Thomas W Geisbert; Lisa E Hensley; Tom Larsen; Howard A Young; Douglas S Reed; Joan B Geisbert; Dana P Scott; Elliott Kagan; Peter B Jahrling; Kelly J Davis
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

10.  Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells.

Authors:  Eduardo Mortola; Rob Noad; Polly Roy
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more
  33 in total

1.  Assays for the identification of novel antivirals against bluetongue virus.

Authors:  Linlin Gu; Stewart W Schneller; Qianjun Li
Journal:  J Vis Exp       Date:  2013-10-11       Impact factor: 1.355

2.  Bluetongue virus infection activates bovine monocyte-derived macrophages and pulmonary artery endothelial cells.

Authors:  Clifton P Drew; Meera C Heller; Christie Mayo; Joie L Watson; N James Maclachlan
Journal:  Vet Immunol Immunopathol       Date:  2010-03-10       Impact factor: 2.046

3.  Bluetongue virus infection alters the impedance of monolayers of bovine endothelial cells as a result of cell death.

Authors:  Clifton P Drew; Ian A Gardner; Christie E Mayo; Eiko Matsuo; Polly Roy; N James MacLachlan
Journal:  Vet Immunol Immunopathol       Date:  2010-03-10       Impact factor: 2.046

4.  NS3 of bluetongue virus interferes with the induction of type I interferon.

Authors:  Emilie Chauveau; Virginie Doceul; Estelle Lara; Emmanuel Breard; Corinne Sailleau; Pierre-Olivier Vidalain; Eliane F Meurs; Stéphanie Dabo; Isabelle Schwartz-Cornil; Stéphan Zientara; Damien Vitour
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

5.  Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo.

Authors:  Teresa Rodríguez-Calvo; José-Manuel Rojas; Verónica Martín; Noemí Sevilla
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

6.  Novel Function of Bluetongue Virus NS3 Protein in Regulation of the MAPK/ERK Signaling Pathway.

Authors:  Damien Vitour; Grégory Caignard; Cindy Kundlacz; Marie Pourcelot; Aurore Fablet; Rayane Amaral Da Silva Moraes; Thibaut Léger; Bastien Morlet; Cyril Viarouge; Corinne Sailleau; Mathilde Turpaud; Axel Gorlier; Emmanuel Breard; Sylvie Lecollinet; Piet A van Rijn; Stephan Zientara
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

7.  A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells.

Authors:  Sarah Gold; Paul Monaghan; Peter Mertens; Terry Jackson
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

8.  Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases.

Authors:  Emilie Chauveau; Virginie Doceul; Estelle Lara; Micheline Adam; Emmanuel Breard; Corinne Sailleau; Cyril Viarouge; Alexandra Desprat; Gilles Meyer; Isabelle Schwartz-Cornil; Suzana Ruscanu; Bernard Charley; Stéphan Zientara; Damien Vitour
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

9.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

10.  Dual modulation of type I interferon response by bluetongue virus.

Authors:  Virginie Doceul; Emilie Chauveau; Estelle Lara; Emmanuel Bréard; Corinne Sailleau; Stéphan Zientara; Damien Vitour
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.